Search for: "MYLAN LABORATORIES LIMITED" Results 61 - 80 of 94
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
15 Apr 2010, 9:20 am by Bexis
Cir. 1996) (not an FDCA case); Mylan Laboratories, Inc. v. [read post]
24 Mar 2010, 4:45 am
Mylan (EPLAW) Colmetec (Olmesartan medoxomil, Hydrochlorothiazide) - France: Cour d'Appel of Paris dismisses appeal of Daiichi Sankyo lodged against decision of French Patent Office rejecting its French SPC: Daiichi Sankyo Company Limited v. [read post]
23 Dec 2009, 12:40 am
(Patent Docs) US: Science Progress article examines impact of gene patents on research (Patent Docs) US: Gene patenting debate continues: round three – Science Friday public debate on National Public Radio (Patent Docs)   Products Circadin (Melatonin) – UK: IPO refuses SPC for Circadin (SPC blog) Dovonex (Calcipoltriol) – UK: EWCA upholds Leo Pharma’s patent: LEO Pharma A/S and LEO Laboratories Limited v. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Mylan Inc., Matrix Laboratories Limited and Matrix Laboratories, Inc. [read post]
25 Nov 2009, 12:00 pm
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://duncanbucknell.com/subscribe/   Highlights this week included: Ecuador to define its compulsory licence legislation (IP Watch) (Patently-O) Tavanic (Levofloxacin) – UK: Supreme Court refuses permission to appeal in Generics (UK) Ltd v Daiichi Pharmaceuticals (The SPC Blog) (JIPLP)   General Nil: The value of patents in a major crisis such as an influenza pandemic – Paper by… [read post]
2 Sep 2009, 11:22 pm
Mylan Laboratories, Inc., 2008 WL 4813311, at *6-7 (D. [read post]
1 Sep 2009, 4:39 am
In April, 2008, the FDA announced a recall of the drug Digitek® (Digoxin) distributed by Mylan Bertek Pharmaceuticals, Inc. and UDL Laboratories, Inc. [read post]
26 Aug 2009, 11:18 pm
Sorry.)In April 2008, the FDA recalled all lots of the drug Digitek (distributed by Mylan and UDL Laboratories), because the tablets may have contained too much of the drug's active ingredient, exposing certain patients to risk.First the recall, then the MDL.The defendants served requests for admission aimed at determining whether plaintiffs' counsel had conducted an adequate prefiling investigation before filing certain complaints. [read post]
20 May 2009, 5:18 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: ACLU, PUBPAT and others file lawsuit challenging constitutionality of patents on human genes associated with breast and ovarian cancer: Association for Molecular Pathology et al v USPTO et al (Patent Baristas) (Ars Technica) (Patently-O) (IP Watchdog) (The Prior Art) (Patent Docs) (Patents4Life) Omnicef (Cefdinir) - US: CAFC rules en banc:… [read post]
19 Nov 2008, 9:04 am
Mylan Laboratories Inc., 2008 WL 4813311 (D.Utah 10/31/08). [read post]
23 Oct 2008, 9:03 am
A small field (limited to the enforcement of FDCA violations), to be sure, but a strategically situated one.The classic definition of field preemption is that "state law is pre-empted where it regulates conduct in a field that Congress intended the Federal Government to occupy exclusively. [read post]
19 Sep 2008, 6:00 pm
: (Techdirt), (Techdirt),   Pharma & Biotech Pharma & Biotech - General Biotech patent law: eleven key pending cases and future developments to watch: (Hal Wegner), (PatentDocs) Study by The Innovation Group highlights damaging intellectual property has been to biotech: (Techdirt), Drug regulatory agencies collaborate on counterfeits, new medical products: (Intellectual Property Watch), Canada: Health Canada releases summary report on industry consultations regarding… [read post]
2 Aug 2008, 12:54 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]